Glycan Analysis Podcast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Glycan Analysis Podcast

Pharmaceutical Technology

 

Welcome to the Basic Training series, providing tutorials, best practices, and podcasts about how to take a product from discovery to development. The series features articles, interviews, and expertise from the global biotechnology industry about bioprocessing with NIBRT, business strategies and models, and technical solutions.

This Podcast was brought to you by

 

BIOPROCESSING BOOT CAMP WITH NIBRT

In BioPharm's Basic Training series, experts from the National Institute for Bioprocess Research and Training (NIBRT) provide in-depth looks at key bioprocessing steps.

Downstream Processing: A Primer
NIBRT's Ian Nelligan on what to expect when starting a downstream process. Posted Oct. 2012.

Upstream Processing: A Primer
NIBRT's Ian Nelligan on on what to expect when starting an upstream process, including the choice between single-use and stainless-steel bioreactors. Posted Sept. 2012.

NIBRT's Ray O'Connor on Aseptic Processing
Ray O'Connor, an operations consultant with NIBRT, addresses aseptic processing, including how to avoid contamination and cleanroom best practices. Posted May 2012.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here